Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janell Fuller is active.

Publication


Featured researches published by Janell Fuller.


The Journal of Pediatrics | 2012

Are Outcomes of Extremely Preterm Infants Improving? Impact of Bayley Assessment on Outcomes

Betty R. Vohr; Bonnie E. Stephens; Rosemary D. Higgins; Carla Bann; Susan R. Hintz; Abhik Das; Jamie E. Newman; Myriam Peralta-Carcelen; Kimberly Yolton; Anna M. Dusick; Patricia W. Evans; Ricki F. Goldstein; Richard A. Ehrenkranz; Athina Pappas; Ira Adams-Chapman; Deanne Wilson-Costello; Charles R. Bauer; Anna Bodnar; Roy J. Heyne; Yvonne E. Vaucher; Robert G. Dillard; Michael J. Acarregui; Elisabeth C. McGowan; Gary J. Myers; Janell Fuller

OBJECTIVES To compare 18- to 22-month cognitive scores and neurodevelopmental impairment (NDI) in 2 time periods using the National Institute of Child Health and Human Developments Neonatal Research Network assessment of extremely low birth weight infants with the Bayley Scales of Infant Development, Second Edition (Bayley II) in 2006-2007 (period 1) and using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley III), with separate cognitive and language scores, in 2008-2011 (period 2). STUDY DESIGN Scores were compared with bivariate analysis, and regression analyses were run to identify differences in NDI rates. RESULTS Mean Bayley III cognitive scores were 11 points higher than mean Bayley II cognitive scores. The NDI rate was reduced by 70% (from 43% in period 1 to 13% in period 2; P < .0001). Multivariate analyses revealed that Bayley III contributed to a decreased risk of NDI by 5 definitions: cognitive score <70 and <85, cognitive or language score <70; cognitive or motor score <70, and cognitive, language, or motor score <70 (P < .001). CONCLUSION Whether the Bayley III is overestimating cognitive performance or whether it is a more valid assessment of emerging cognitive skills than the Bayley II is uncertain. Because the Bayley III identifies significantly fewer children with disability, it is recommended that all extremely low birth weight infants be offered early intervention services at the time of discharge from the neonatal intensive care unit, and that Bayley scores be interpreted with caution.


The New England Journal of Medicine | 2012

Neurodevelopmental Outcomes in the Early CPAP and Pulse Oximetry Trial

Yvonne E. Vaucher; Myriam Peralta-Carcelen; Neil N. Finer; Waldemar A. Carlo; Marie G. Gantz; Michele C. Walsh; Abbot R. Laptook; Bradley A. Yoder; Roger G. Faix; Abhik Das; Kurt Schibler; Wade Rich; Nancy S. Newman; Betty R. Vohr; Kimberly Yolton; Roy J. Heyne; Deanne Wilson-Costello; Patricia W. Evans; Ricki F. Goldstein; Michael J. Acarregui; Ira Adams-Chapman; Athina Pappas; Susan R. Hintz; Brenda B. Poindexter; Anna M. Dusick; Elisabeth C. McGowan; Richard A. Ehrenkranz; Anna Bodnar; Charles R. Bauer; Janell Fuller

BACKGROUND Previous results from our trial of early treatment with continuous positive airway pressure (CPAP) versus early surfactant treatment in infants showed no significant difference in the outcome of death or bronchopulmonary dysplasia. A lower (vs. higher) target range of oxygen saturation was associated with a lower rate of severe retinopathy but higher mortality. We now report longer-term results from our prespecified hypotheses. METHODS Using a 2-by-2 factorial design, we randomly assigned infants born between 24 weeks 0 days and 27 weeks 6 days of gestation to early CPAP with a limited ventilation strategy or early surfactant administration and to lower or higher target ranges of oxygen saturation (85 to 89% or 91 to 95%). The primary composite outcome for the longer-term analysis was death before assessment at 18 to 22 months or neurodevelopmental impairment at 18 to 22 months of corrected age. RESULTS The primary outcome was determined for 1234 of 1316 enrolled infants (93.8%); 990 of the 1058 surviving infants (93.6%) were evaluated at 18 to 22 months of corrected age. Death or neurodevelopmental impairment occurred in 27.9% of the infants in the CPAP group (173 of 621 infants), versus 29.9% of those in the surfactant group (183 of 613) (relative risk, 0.93; 95% confidence interval [CI], 0.78 to 1.10; P=0.38), and in 30.2% of the infants in the lower-oxygen-saturation group (185 of 612), versus 27.5% of those in the higher-oxygen-saturation group (171 of 622) (relative risk, 1.12; 95% CI, 0.94 to 1.32; P=0.21). Mortality was increased with the lower-oxygen-saturation target (22.1%, vs. 18.2% with the higher-oxygen-saturation target; relative risk, 1.25; 95% CI, 1.00 to 1.55; P=0.046). CONCLUSIONS We found no significant differences in the composite outcome of death or neurodevelopmental impairment among extremely premature infants randomly assigned to early CPAP or early surfactant administration and to a lower or higher target range of oxygen saturation. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute; SUPPORT ClinicalTrials.gov number, NCT00233324.).


Pediatrics | 2015

Neuroimaging and Neurodevelopmental Outcome in Extremely Preterm Infants

Susan R. Hintz; Patrick D. Barnes; Dorothy I. Bulas; Thomas L. Slovis; Neil N. Finer; Lisa A. Wrage; Abhik Das; Jon E. Tyson; David K. Stevenson; Waldemar A. Carlo; Michele C. Walsh; Abbot R. Laptook; Bradley A. Yoder; Krisa P. Van Meurs; Roger G. Faix; Wade Rich; Nancy S. Newman; Helen Cheng; Roy J. Heyne; Betty R. Vohr; Michael J. Acarregui; Yvonne E. Vaucher; Athina Pappas; Myriam Peralta-Carcelen; Deanne Wilson-Costello; Patricia W. Evans; Ricki F. Goldstein; Gary J. Myers; Brenda B. Poindexter; Elisabeth C. McGowan

BACKGROUND: Extremely preterm infants are at risk for neurodevelopmental impairment (NDI). Early cranial ultrasound (CUS) is usual practice, but near-term brain MRI has been reported to better predict outcomes. We prospectively evaluated MRI white matter abnormality (WMA) and cerebellar lesions, and serial CUS adverse findings as predictors of outcomes at 18 to 22 months’ corrected age. METHODS: Early and late CUS, and brain MRI were read by masked central readers, in a large cohort (n = 480) of infants <28 weeks’ gestation surviving to near term in the Neonatal Research Network. Outcomes included NDI or death after neuroimaging, and significant gross motor impairment or death, with NDI defined as cognitive composite score <70, significant gross motor impairment, and severe hearing or visual impairment. Multivariable models evaluated the relative predictive value of neuroimaging while controlling for other factors. RESULTS: Of 480 infants, 15 died and 20 were lost. Increasing severity of WMA and significant cerebellar lesions on MRI were associated with adverse outcomes. Cerebellar lesions were rarely identified by CUS. In full multivariable models, both late CUS and MRI, but not early CUS, remained independently associated with NDI or death (MRI cerebellar lesions: odds ratio, 3.0 [95% confidence interval: 1.3–6.8]; late CUS: odds ratio, 9.8 [95% confidence interval: 2.8–35]), and significant gross motor impairment or death. In models that did not include late CUS, MRI moderate-severe WMA was independently associated with adverse outcomes. CONCLUSIONS: Both late CUS and near-term MRI abnormalities were associated with outcomes, independent of early CUS and other factors, underscoring the relative prognostic value of near-term neuroimaging.


Pediatrics | 2014

Cognitive Outcomes of Preterm Infants Randomized to Darbepoetin, Erythropoietin, or Placebo

Robin K. Ohls; Kamath-Rayne Bd; Robert D. Christensen; Susan E. Wiedmeier; Adam A. Rosenberg; Janell Fuller; Conra Backstrom Lacy; Mashid Roohi; Diane K. Lambert; Jill J. Burnett; Pruckler B; Peceny H; Daniel C. Cannon; Lowe

BACKGROUND: We previously reported decreased transfusions and donor exposures in preterm infants randomized to Darbepoetin (Darbe) or erythropoietin (Epo) compared with placebo. As these erythropoiesis-stimulating agents (ESAs) have shown promise as neuroprotective agents, we hypothesized improved neurodevelopmental outcomes at 18 to 22 months among infants randomized to receive ESAs. METHODS: We performed a randomized, masked, multicenter study comparing Darbe (10 μg/kg, 1×/week subcutaneously), Epo (400 U/kg, 3×/week subcutaneously), and placebo (sham dosing 3×/week) given through 35 weeks’ postconceptual age, with transfusions administered according to a standardized protocol. Surviving infants were evaluated at 18 to 22 months’ corrected age using the Bayley Scales of Infant Development III. The primary outcome was composite cognitive score. Assessments of object permanence, anthropometrics, cerebral palsy, vision, and hearing were performed. RESULTS: Of the original 102 infants (946 ± 196 g, 27.7 ± 1.8 weeks’ gestation), 80 (29 Epo, 27 Darbe, 24 placebo) returned for follow-up. The 3 groups were comparable for age at testing, birth weight, and gestational age. After adjustment for gender, analysis of covariance revealed significantly higher cognitive scores among Darbe (96.2 ± 7.3; mean ± SD) and Epo recipients (97.9 ± 14.3) compared with placebo recipients (88.7 ± 13.5; P = .01 vs ESA recipients) as was object permanence (P = .05). No ESA recipients had cerebral palsy, compared with 5 in the placebo group (P < .001). No differences among groups were found in visual or hearing impairment. CONCLUSIONS: Infants randomized to receive ESAs had better cognitive outcomes, compared with placebo recipients, at 18 to 22 months. Darbe and Epo may prove beneficial in improving long-term cognitive outcomes of preterm infants.


The Journal of Pediatrics | 2014

Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).

Timothy P. Stevens; Neil N. Finer; Waldemar A. Carlo; Peter G. Szilagyi; Dale L. Phelps; Michele C. Walsh; Marie G. Gantz; Abbot R. Laptook; Bradley A. Yoder; Roger G. Faix; Jamie E. Newman; Abhik Das; Barbara T. Do; Kurt Schibler; Wade Rich; Nancy S. Newman; Richard A. Ehrenkranz; Myriam Peralta-Carcelen; Betty R. Vohr; Deanne Wilson-Costello; Kimberly Yolton; Roy J. Heyne; Patricia W. Evans; Yvonne E. Vaucher; Ira Adams-Chapman; Elisabeth C. McGowan; Anna Bodnar; Athina Pappas; Susan R. Hintz; Michael J. Acarregui

OBJECTIVE To explore the early childhood pulmonary outcomes of infants who participated in the National Institute of Child Health and Human Developments Surfactant Positive Airway Pressure and Pulse Oximetry Randomized Trial (SUPPORT), using a factorial design that randomized extremely preterm infants to lower vs higher oxygen saturation targets and delivery room continuous positive airway pressure (CPAP) vs intubation/surfactant. STUDY DESIGN The Breathing Outcomes Study, a prospective secondary study to the Surfactant Positive Airway Pressure and Pulse Oximetry Randomized Trial, assessed respiratory morbidity at 6-month intervals from hospital discharge to 18-22 months corrected age (CA). Two prespecified primary outcomes-wheezing more than twice per week during the worst 2-week period and cough longer than 3 days without a cold-were compared for each randomized intervention. RESULTS One or more interviews were completed for 918 of the 922 eligible infants. The incidences of wheezing and cough were 47.9% and 31.0%, respectively, and did not differ between the study arms of either randomized intervention. Infants randomized to lower vs higher oxygen saturation targets had a similar risk of death or respiratory morbidity (except for croup and treatment with oxygen or diuretics at home). Infants randomized to CPAP vs intubation/surfactant had fewer episodes of wheezing without a cold (28.9% vs 36.5%; P<.05), respiratory illnesses diagnosed by a doctor (47.7% vs 55.2%; P<.05), and physician or emergency room visits for breathing problems (68.0% vs 72.9%; P<.05) by 18-22 months CA. CONCLUSION Treatment with early CPAP rather than intubation/surfactant is associated with less respiratory morbidity by 18-22 months CA. Longitudinal assessment of pulmonary morbidity is necessary to fully evaluate the potential benefits of respiratory interventions for neonates.


Journal of Developmental and Behavioral Pediatrics | 2012

Screening for Autism Spectrum Disorders in Extremely Preterm Infants

Bonnie E. Stephens; Carla Bann; Victoria E. Watson; Stephen J. Sheinkopf; Myriam Peralta-Carcelen; Anna Bodnar; Kimberly Yolton; Ricki F. Goldstein; Anna M. Dusick; Deanne Wilson-Costello; Michael J. Acarregui; Athina Pappas; Ira Adams-Chapman; Elisabeth C. McGowan; Roy J. Heyne; Susan R. Hintz; Richard A. Ehrenkranz; Janell Fuller; Abhik Das; Rosemary D. Higgins; Betty R. Vohr

Background: Extremely preterm (EP) infants screen positive for autism spectrum disorders (ASD) at high rates. However, it is not clear whether this is because of high rates of ASD in EPs or to high rates of false-positive screens for ASD in children with a high rate of underlying neurodevelopmental impairments. Combining a parent questionnaire designed to distinguish developmental delay from ASD with direct observation of infant behavior may more accurately screen for ASD in EPs. Objectives: To determine rates of positive screen for ASD at 18 to 22 months(m) in EPs using 3 screens; to determine factors associated with a positive screen. Methods: Five hundred fifty-four infants born <27 weeks were screened at 18 to 22 m using the Pervasive Developmental Disorders Screening test, second edition Stage 2, and the response to name and response to joint attention items from the Autism Diagnostic Observation Schedule. Infants with severe cerebral palsy, deafness, and blindness were excluded. Associations between positive screen and neonatal/ infant characteristics were determined. Results: Of 554 infants, 113 (20%) had ≥ 1 positive screen. 10% had a positive Pervasive Developmental Disorders Screening test, second edition, 6% response to name, 9% response to joint attention; in only 1 % all 3 screens were positive. Positive screen was associated with male gender, more hospital days, white race, lower maternal education, abnormal behavioral scores, and cognitive/ language delay. Conclusions: The use of 3 screens for ASD in EPs results in higher screen positive rates than use of 1 screen alone. Diagnostic confirmation is needed before true rates of ASD in EPs are known.


Acta Paediatrica | 2013

Association of maternal scaffolding to maternal education and cognition in toddlers born preterm and full term.

Jean R. Lowe; Sarah J. Erickson; Peggy MacLean; Ronald Schrader; Janell Fuller

Parental behaviour described as ‘scaffolding’ has been shown to influence outcomes in at‐risk children. The purpose of this study was to compare maternal verbal scaffolding in toddlers born preterm and full term.


Early Human Development | 2013

Early working memory as a racially and ethnically neutral measure of outcome in extremely preterm children at 18–22 months

Jean R. Lowe; Andrea F. Duncan; Carla Bann; Janell Fuller; Susan R. Hintz; Abhik Das; Rosemary D. Higgins; Kristi L. Watterberg

BACKGROUND Difficulties with executive function have been found in preterm children, resulting in difficulties with learning and school performance. AIM This study evaluated the relationship of early working memory as measured by object permanence items to the cognitive and language scores on the Bayley Scales-III in a cohort of children born extremely preterm. STUDY DESIGN Logistic regression models were conducted to compare object permanence scores derived from the Bayley Scales-III by race/ethnicity and maternal education, controlling for medical covariates. SUBJECTS Extremely preterm toddlers (526), who were part of a Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Networks multi-center study, were evaluated at 18-22 months corrected age. OUTCOME MEASURES Object permanence scores derived from the Bayley Developmental Scales were compared by race/ethnicity and maternal education, controlling for medical covariates. RESULTS There were no significant differences in object permanence mastery and scores among the treatment groups after controlling for medical and social variables, including maternal education and race/ethnicity. Males and children with intraventricular hemorrhage, retinopathy of prematurity, and bronchopulmonary dysplasia were less likely to demonstrate object permanence mastery and had lower object permanence scores. Children who attained object permanence mastery had significantly higher Bayley Scales-III cognitive and language scores after controlling for medical and socio-economic factors. CONCLUSIONS Our measure of object permanence is free of influence from race, ethnic and socio-economic factors. Adding this simple task to current clinical practice could help detect early executive function difficulties in young children.


Pediatrics | 2018

Preterm Neuroimaging and School-Age Cognitive Outcomes

Susan R. Hintz; Betty R. Vohr; Carla Bann; H. Gerry Taylor; Abhik Das; Kathryn E. Gustafson; Kimberly Yolton; Victoria E. Watson; Jean R. Lowe; Maria Elena DeAnda; M. Bethany Ball; Neil N. Finer; Krisa P. Van Meurs; Seetha Shankaran; Athina Pappas; Patrick D. Barnes; Dorothy I. Bulas; Jamie E. Newman; Deanne Wilson-Costello; Roy J. Heyne; Heidi M. Harmon; Myriam Peralta-Carcelen; Ira Adams-Chapman; Andrea F. Duncan; Janell Fuller; Yvonne E. Vaucher; Tarah T. Colaizy; Sarah Winter; Elisabeth C. McGowan; Ricki F. Goldstein

With this prospective, multicenter study of infants born EPT, we assess the relative value of neonatal neuroimaging to predict cognitive impairment and disability at school age. BACKGROUND AND OBJECTIVES: Children born extremely preterm are at risk for cognitive difficulties and disability. The relative prognostic value of neonatal brain MRI and cranial ultrasound (CUS) for school-age outcomes remains unclear. Our objectives were to relate near-term conventional brain MRI and early and late CUS to cognitive impairment and disability at 6 to 7 years among children born extremely preterm and assess prognostic value. METHODS: A prospective study of adverse early and late CUS and near-term conventional MRI findings to predict outcomes at 6 to 7 years including a full-scale IQ (FSIQ) <70 and disability (FSIQ <70, moderate-to-severe cerebral palsy, or severe vision or hearing impairment) in a subgroup of Surfactant Positive Airway Pressure and Pulse Oximetry Randomized Trial enrollees. Stepwise logistic regression evaluated associations of neuroimaging with outcomes, adjusting for perinatal-neonatal factors. RESULTS: A total of 386 children had follow-up. In unadjusted analyses, severity of white matter abnormality and cerebellar lesions on MRI and adverse CUS findings were associated with outcomes. In full regression models, both adverse late CUS findings (odds ratio [OR] 27.9; 95% confidence interval [CI] 6.0–129) and significant cerebellar lesions on MRI (OR 2.71; 95% CI 1.1–6.7) remained associated with disability, but only adverse late CUS findings (OR 20.1; 95% CI 3.6–111) were associated with FSIQ <70. Predictive accuracy of stepwise models was not substantially improved with the addition of neuroimaging. CONCLUSIONS: Severe but rare adverse late CUS findings were most strongly associated with cognitive impairment and disability at school age, and significant cerebellar lesions on MRI were associated with disability. Near-term conventional MRI did not substantively enhance prediction of severe early school-age outcomes.


Acta Paediatrica | 2018

When lightning strikes: a case of early childhood outcome following maternal lightning strike

Jessie R. Maxwell; Christina Kamm; Courtney D. Grassham; Janell Fuller; Jean R. Lowe; Vlad Ianus

Lightning is a natural phenomenon, striking within the United States more than 20 million times per year(1). The reports of impact a lightning strike has on pregnant women and the fetus is varied, with some reports revealing significant fetal mortality and others reporting no major fetal risk(1). A case report including 31 pregnant women with electrical injuries reported the risk of fetal death to be 15%(2). This article is protected by copyright. All rights reserved.

Collaboration


Dive into the Janell Fuller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Deanne Wilson-Costello

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Myriam Peralta-Carcelen

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Roy J. Heyne

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean R. Lowe

University of New Mexico

View shared research outputs
Researchain Logo
Decentralizing Knowledge